Amylyx Pharmaceuticals company profile
Pioneering breakthroughs in neurodegenerative treatment with passion and precision.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals is a biopharmaceutical company committed to developing new treatments for debilitating neurodegenerative diseases. Headquartered in the United States with a growing presence in the UK, the company is focused on harnessing innovative research and development strategies to improve patient outcomes. Amylyx is dedicated to pushing the boundaries of science to address unmet medical needs. With a dynamic team of scientists and industry professionals, they strive to deliver hope to those affected while maintaining a robust pipeline of potential therapies.
Industry: Biotechnology
Location: UK